loader from loading.io

Tom and Sheri Eckert - Oregon Psilocybin Therapy Initiative

Psychedelics Today

Release Date: 05/05/2020

Solidarity Fridays - Week 25 show art Solidarity Fridays - Week 25

Psychedelics Today

In today’s Solidarity Fridays episode, Joe and Kyle discuss recent items in the news and dive into cannabis-assisted psychotherapy after Joe recently helped with his first session. They discuss Compass Pathways' projection that their upcoming stock price could be $14-$16 a share, giving them a possible valuation of as much as $544 million and the problem of having Peter Thiel as one of their leading investors, as it has recently come to surface that he met with white nationalists in 2016 and had good things to say about them. This, in addition to his concerning data-mining company, Palantir...

info_outline
Ash - CBD, Nootropics, and Micro1p show art Ash - CBD, Nootropics, and Micro1p

Psychedelics Today

In this episode, Joe interviews Ash: Netherlands-based psychedelic entrepreneur with his hands in many psychedelic spaces- drug manufacturing company Synergy Trading, nootropics company Cerebra Nootropics, and podcast, Shifty Perspective.   Ash talks about his path from trying San Pedro on a farm, to trying DMT and living on the road and in squats for years, to moving to Belgium from the UK, to finding his way into the world of CBD after a friend recommended it for his epileptic girlfriend at the time. When she went from 12 seizures a day to none within a month of starting regular...

info_outline
Solidarity Fridays - Week 24 show art Solidarity Fridays - Week 24

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss several recent items in the news that further the advancement of psychedelics, including: Canadian company Havn Lifescience following Compass Pathways' lead and registering with the Canadian Securities Exchange under the symbol HAVN, Amsterdam-based psychedelic retreat company Synthesis announcing that leading Clinical Psychologist Dr. Rosalind Watts has joined their advisory board (which also includes Dr. Robin Carhart-Harris, who joined in November), European psychedelic-assisted psychotherapy company AWAKN Life Sciences Inc....

info_outline
Wade Davis - Ayahuasca and a New Hope for Colombia show art Wade Davis - Ayahuasca and a New Hope for Colombia

Psychedelics Today

In this episode, Joe interviews Wade Davis: Ph.D., Professor of Anthropology at the University of British Columbia, explorer, ethnobotanist, star of the recent documentary, "El Sendero de la Anaconda," and author of several books, including  bestseller The Serpent and the Rainbow, which was optioned for a movie, starring Bill Pullman and released by Universal Pictures in 1988. His new book, Magdalena: River of Dreams: A Story of Colombia, comes out on September 15th.  Wade discusses his history with Richard Evans Schultes, the strange phenomenon behind the growth of ayahuasca...

info_outline
Solidarity Fridays - Week 23 show art Solidarity Fridays - Week 23

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss recent items in the news. They cover a new LSD microdose trial to study the effects of 5, 10, or 20 µg on acute pain, seeing how long participants could hold their hands in 37.4° F water. Led by researchers from Maastricht University with help from the Beckley Foundation, this is the first study of its kind since Eric Kast first studied the effects of LSD on acute pain in the 1960s, and could help lead to LSD being prescribed for acute pain over the more standard and very addictive and dangerous opioids. This leads towards the topic...

info_outline
Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens show art Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens

Psychedelics Today

In this episode, Joe and Kyle interview Sara Reed, MS, LMFT, creator of Mind's Eye Health Solutions, and Director of Psychedelic Services at the Behavioral Wellness Clinic in Connecticut. Reed talks about her path to psychedelics- from graduating with a masters in emerging family therapy and wanting to do research specifically with black Americans, to working with Dr. Monica Williams and eventually MAPS, to being selected as one of the therapists for a phase 3 MDMA-assisted psychotherapy trial (which focused on people of color), to making the transition from practicing with MDMA to ketamine...

info_outline
Solidarity Fridays - Week 22 show art Solidarity Fridays - Week 22

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle have, in Joe's words, "a wildly rambling show." They cover topics in the news, including MAPS' recent completion of their Capstone Campaign, a non-profit fundraising effort to fund the final research required to seek FDA approval of MDMA-assisted psychotherapy (through which they raised $30 million from several high-profile names), MindMed's new LSD-MDMA "candy flipping" phase 1 trial set to commence later this year, Representative Earl Blumenauer's (D-OR) fundraising efforts for legal psilocybin and Oregon's ballot initiative becoming a...

info_outline
Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity show art Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity

Psychedelics Today

In this episode, Joe interviews Dr. LaMisha Hill, licensed Counseling Psychologist, board member of the Alameda County Psychological Association, and Director of Multicultural Affairs for the Office of Diversity and Outreach at the University of California, San Francisco. Hill talks about how race and gender of underrepresented people come into play in the psychedelic sphere- in studies, professions, and even in people's consideration of psychedelics as a possible healer for them: how most psychology follows the same well-worn, Euro-centric, fairly western, mostly-for-well-off-college-students...

info_outline
Solidarity Fridays - Week 21 show art Solidarity Fridays - Week 21

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle sit down and discuss recent items in the news, including the passing of Tav Sparks; author, therapist, co-director of Grof Transpersonal Training, and creator of "Movie Yoga," and scientist Jordi Riba; one of the early pioneers of ayahuasca research and one of the first ever to bring it into the lab.  They discuss the ayahuasca episode of the new Netflix docuseries "Unwell," and 2 articles from Marijuana Moment: psychedelic activists in Oakland creating a guideline for plant medicine healing ceremonies and the new initiative to allow for...

info_outline
Jerry and Julie Brown - Healing Through Mystical Experience show art Jerry and Julie Brown - Healing Through Mystical Experience

Psychedelics Today

In this episode, Joe interviews Jerry and Julie Brown. Jerry (Ph.D.) is an author and activist, who served as founding professor of anthropology at Florida International University in Miami for 42 years. Julie (M.A.) is an author and integrative psychotherapist, who worked with cancer patients with a focus on guided imagery. Together, they are co-authors of The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity. They talk about their  on Psychedelics Today and inspiring studies: Walter Pahnke’s original psilocybin study at Marsh Chapel and Roland Griffiths’...

info_outline
 
More Episodes

In this episode, Joe interviews Tom and Sheri Eckert, organizers of the Oregon Psilocybin Therapy Initiative. The IP 34 is the bill that would legalize psilocybin therapy.

3 Key Points:

  1. IP 34 asks the Oregon Health Authority to create a licensing system that will create a regulated program where Oregonians suffering from depression, anxiety, trauma and other challenges can see a licensed and trained facilitator to receive supervised psilocybin therapy.
  2. IP 34 was written by licensed therapists in Oregon along with the country’s leading advocates in the field. It is supported by healthcare professionals, treatment providers, veterans’ groups and community leaders across the state.
  3. There has been a multitude of studies from leading medical research institutions such as Johns Hopkins, UCLA, and NYU showing that psilocybin therapy works.

Support the show

Navigating Psychedelics


Show Notes

About

  • Tom and Sheri began their interest in psilocybin research about 5 years ago when they read an article in The New Yorker by Michal Pollan
  • They realized how powerful psilocybin was for clinical work
  • They are both therapists, and were inspired to find out if there was a way to create a modality that allowed them to provide psilocybin therapy to help their clients

Psilocybin Assisted Psychotherapy

  • Psychotherapy is supposed to be experiential, the breakthrough is where the change happens
  • Sheri says that psilocybin therapy gets all parts of the brain in communication together
  • “The more intense the mystical experience the more clinical outcomes that are achieved” - Tom

Ballot Initiative

  • They started in 2015
  • They wanted the breakthrough studies and the research proving low risks to work for them
  • The psychedelic community was very helpful
  • They went through rotations with the way the initiative was written
  • They like the therapy model, its safe, careful and mindful

Clause

  • Joe asks about a Supremacy Clause, where the state supersedes local districts
    • This initiative does not get in the way of any other initiative
  • There are angles on all different types of drug policy reform
  • There is nothing in the IP34 that blocks any other initiative like decriminalization
    • We are all a part of the big picture, we all need to work together

GMP Psilocybin

  • They wanted to keep this in the frame of non-commercialization
    • Their goal with this is not about money, it’s really about the healing
    • “We are trying to move forward a healing modality to help people, we are trying to legalize psilocybin assisted psychotherapy” - Tom
  • There is a part in the initiative that says measures will have to be taken to make sure the psilocybin is ‘food grade’ standard or in general just clean and safe

Oregonians to Sign the Petition

  • Download the petition, sign it, and mail it in

Final Thoughts

  • Sheri says that the team behind the initiative is inspired by what is happening globally around psilocybin and research
  • They are right at the end of their signatures, but they need help to reach the goal
  • “We've got to see the bigger picture here, and get behind it.” - Tom

Links

Website


About Tom and Sheri Eckert

As husband-and-wife founders of the Oregon Psilocybin Society (OPS) and authors of the Psilocybin Service Initiative (PSI), Tom and Sheri Eckert have set in motion a historic campaign to legalize Psilocybin Services, also known as Psilocybin Assisted Therapy, in their home state of Oregon. A growing number of Oregonians are getting behind the idea, largely in response to the latest science. The Eckerts, with a growing army of volunteers, are spreading a truth held increasingly self-evident: that the psilocybin experience, when facilitated under safe and supportive conditions, can be a life-changing gift.In addition to their activism, the Eckert’s own and operate “Innerwork” – a private psychotherapy practice serving the Portland metro area. Included in their catalog of services is their groundbreaking “Better Man” program, which is shown to neutralize intimate partner and family violence. Sheri has been awarded a Cosmic Sister Women of the Psychedelic Renaissance in support of her presentation at the Spirit Plant Medicine conference.

Designed to help the body with cellular energy and cardiovascular endurance.

Get a 30 day free audible trial at audibletrial.com/psychedelicstoday